Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Summary
The National Cancer Institute (NCI) is preparing to publish a Notice of Funding Opportunity (NOFO) to solicit Small Business Innovation Research (SBIR) applications aimed at supporting the commercialization of cancer-relevant projects previously funded under SBIR or STTR Phase II awards. Eligible applicants include small businesses, nonprofits, government entities, and educational institutions. While applications are not currently being accepted, the NOFO is expected to be published in Summer 2025, with applications due in Fall 2025, and interested parties are encouraged to develop collaborations and projects in the meantime.
Full description
Description
The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this NOFO is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This NOFO is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R44 activity code. The NOFO is expected to be published in Summer 2025 with an anticipated application due date in Fall 2025.
Eligibility
Eligible applicants
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- Public and Indian housing authorities
- State governments
- County governments
- Federally recognized Native American tribal governments
Business
- Small businesses
- For-profit organizations other than small businesses
Education
- Public and state institutions of higher education
- Independent school districts
- Private institutions of higher education
Additional information
Grantor contact information
Description
francakohjc@mail.nih.gov
Recommended Resource
Grant Writing Services on Fiverr
Struggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.
Get started now